Providing consultancy and leadership support in the life sciences.Skills: R&D Digital Health, Supply Chain Management, Pharmaceutical Process DevelopmentDigital Transformation, Clinical Research, Enterprise Resource Planning, Program Management, People Development, Team Leadership, Driving Results, Change Management

Providing leadership and consulting services across Life Science programmes

Leading a global digital recruitment transformation programme to significantly increase the number and diversity of patients joining clinical trials. Key technology focus areas include: (1) social media education and engagement; (2) patient data search including AA/AI; (3) improved clinical recruitment workflow and (4) hospital and healthcare partnerships. Over 2000 potential patients have now joined "virtual waiting rooms" across oncology and respiratory therapy areas and > 100 patients have enrolled on clinical trials.

Founding member of the AstraZeneca R&D Digital Health Leadership team. In 5 years, this transformational new function introduced digital health solutions to clinical trials demonstrating improvement in patient experience, accelerated clinical timelines and reduced costs. Solutions included remote patient monitoring devices, remote therapeutic devices, integration with a bespoke digital platform for patients and sites in trials, study design with AI, patient at home supply and digital patient recruitment. Ground-breaking trials demonstrating the impact of digital solutions have included DAPA-MI (cardiovascular) and CRESCENDO (COPD). This function has now become a separate business unit within AstraZeneca offering globally-scaled digital products and services to the life sciences and healthcare sector.

Led a global digital transformation programme to significantly increase clinical supply chain efficiency, agility and customer centricity through technology innovation including: (1) using advanced analytics in design / planning and (2) automated just in time manufacturing and (3) demand driven supply planning. Generated > $100M of cost savings through reducing medicine waste.

Created a clinical supply chain “Centre of Excellence” team that built new global capabilities including demand and supply planning (project, portfolio and analytics based decision making), a state-of-the-art Enterprise Resource Planning (ERP) platform, business-aligned performance measurement/control, optimised processes, distribution enhancements (sea-freight instead of air, optimising packing volume and frequency, re-usable shippers) and labelling improvements (programme labels which reduce inventory waste). The largest and most complex global change programme that I have led was the replacement of our ageing, obsolete ERP platform. The scope included all aspects from early vendor evaluation, business case development, implementation and decommissioning of the existing system. This was the largest ever IT project for Clinical Supply Chain with a 3 year timeline and up to 30 FTEs involved during implementation. The programme has delivered 5 software modules, new IT infrastructure (servers, middleware), external interfacing capability with key supply chain partners, enterprise reporting, data archiving and migration, new business processes and a simplified quality management system.

I led cross-functional teams to deliver process development, supply and regulatory needs for R&D projects through appropriate an appropriate strategy, scope development, planning, risk and stakeholder management activities. My accountability included a diverse oncology / infection portfolio ranging from preclinical to late stage development programmes. As a member of numerous R&D "Brand" Teams, I helped to shape the overall drug development strategy and ensured our pharmaceutical development strategy aligned with this.

I led a team of Process Engineers supporting technical scale-up and manufacturing activities for drug substance for a range of development projects across multiple therapy areas through Phase I to III development

I led a team of engineers and analytical chemists supporting commercial products including day-to-day process troubleshooting, abnormality resolution, process improvements and installation of new equipment. This included leading Prior Approval Supplement (PAS) and technology transfer activities to manufacturing sites in Rahway (US), Barceloneta (Puerto Rico) and Singapore

I led development activities for new and existing toothpaste products for the European market. I also led technology transfer activities for new formulations to Operations in Mainz (Germany)